Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Xpress
Researchers reported changes in brain functional connectivity after adding N-acetylcysteine to ongoing multiple sclerosis treatment, an early imaging signal that requires confirmation in larger studies with defined dosing and clinical outcomes.
Clinical Pharmacology November 3rd 2026
Annals of Internal Medicine
First-trimester benzodiazepine exposure was not associated with a meaningful increase in major congenital malformations in a large US cohort study, although findings related to coexposure with other psychoactive medications remained inconsistent and require further investigation.
Clinical Pharmacology October 20th 2026
Psych Congress Network
A systematic review of 12 studies found that vortioxetine consistently improved depressive symptoms in adults aged 65 years and older with major depressive disorder, but evidence for cognitive benefits remained mixed and largely confined to selected cognitive domains.
Behavioral Health October 9th 2026
Psychiatrist.com
A single-day inhaled mebufotenin regimen produced rapid, sustained symptom reductions through day 8 in 10 patients with postpartum depression, but the uncontrolled trial provides an early clinical signal rather than comparative efficacy evidence.
Clinical Pharmacology October 9th 2026
A novel liposomal drug-delivery system prolonged tetrodotoxin nerve blockade to two to three weeks in rats, substantially exceeding currently available formulations. The findings highlight a potential strategy for sustained local anesthetic delivery, although clinical relevance remains unproven pending human validation.
Anesthesiology October 7th 2026
Medical News Today (MNT)
Experts reviewing available evidence suggest melatonin and magnesium may support sleep through different mechanisms, though benefits appear dependent on the underlying cause of sleep disturbance and overall evidence remains mixed, particularly for magnesium.
Behavioral Health October 1st 2026